LGALS9 Mouse

Galectin-9 Mouse Recombinant
Cat. No.
BT11659
Source
Escherichia Coli.
Synonyms
Galectin-9, Gal-9, Lgals9, Lgals5, LGALS35, AA407335, AI194909, AI265545.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

LGALS9 mouse Recombinant produced E. coli is a single polypeptide chain containing 345 amino acids (1-322) and having a molecular mass of 38kDa.
LGALS9 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
LGALS9, also known as Galectin-9, is a protein that binds to galactosides and exhibits a high affinity for the Forssman pentasaccharide. It plays a crucial role in thymocyte-epithelial cell interactions, which are essential for thymus function. LGALS9 is involved in inhibiting cell proliferation and serves as a ligand for HAVCR2/TIM3. It induces the death of T helper type 1 lymphocytes (Th1) and acts as an eosinophil chemoattractant. As an S-type lectin, LGALS9 is overexpressed in Hodgkin's disease tissue and participates in interactions between Hodgkin and Reed-Sternberg (H&RS) cells and their surrounding cells.
Description
Recombinant LGALS9 from mouse, produced in E. coli, is a single polypeptide chain consisting of 345 amino acids (residues 1-322) with a molecular weight of 38 kDa. The protein includes a 23 amino acid His-tag fused at the N-terminus. Purification is achieved using proprietary chromatographic techniques.
Physical Appearance
Sterile, colorless solution that has been filtered.
Formulation
The LGALS9 solution is provided at a concentration of 0.5 mg/ml in a buffer consisting of 20 mM Tris-HCl (pH 8.0), 0.4 M Urea, and 10% glycerol.
Stability
For short-term storage (2-4 weeks), keep at 4°C. For extended storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is advised for long-term storage. Frequent freeze-thaw cycles should be avoided.
Purity
The purity is determined to be greater than 90.0% using SDS-PAGE analysis.
Synonyms
Galectin-9, Gal-9, Lgals9, Lgals5, LGALS35, AA407335, AI194909, AI265545.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMALFSAQ SPYINPIIPF TGPIQGGLQE GLQVTLQGTT KSFAQRFVVN FQNSFNGNDI AFHFNPRFEE GGYVVCNTKQ NGQWGPEERK MQMPFQKGMP FELCFLVQRS EFKVMVNKKF FVQYQHRVPY HLVDTIAVSG CLKLSFITFQ TQNFRPAHQA PMAQTTIHMV HSTPGQMFST PGIPPVVYPT PAYTIPFYTP IPNGLYPSKS IMISGNVLPD ATRFHINLRC GGDIAFHLNP RFNENAVVRN TQINNSWGQE ERSLLGRMPF SRGQSFSVWI ICEGHCFKVA VNGQHMCEYY HRLKNLQDIN TLEVAGDIQL THVQT.

Product Science Overview

Introduction

Galectin-9 is a member of the galectin family, which comprises multifunctional carbohydrate-binding proteins with specificity for N-acetyl-lactosamine-containing glycoproteins. Galectins are involved in various biological processes, including cell-cell adhesion, cell-matrix interactions, and immune response modulation. Galectin-9, in particular, has garnered significant interest due to its diverse roles in immune regulation and potential therapeutic applications.

Structure and Isoforms

Galectin-9 is a tandem-repeat type galectin, meaning it contains two carbohydrate recognition domains (CRDs) connected by a linker region . The full-length Galectin-9 protein is approximately 39 kDa in size. Alternative splicing of the Galectin-9 gene can generate different isoforms, including a small intestine-specific isoform with a 31 amino acid insertion in the linker region .

Expression and Function

Galectin-9 is widely expressed in various tissues, including the thymus, spleen, liver, and gastrointestinal tract. It plays a crucial role in modulating immune responses, particularly in the context of T-cell regulation. Galectin-9 can induce apoptosis in T-cells, thereby contributing to the maintenance of immune homeostasis and the prevention of autoimmune diseases .

In addition to its immunomodulatory functions, Galectin-9 has been implicated in various pathological conditions, including cancer, infectious diseases, and inflammatory disorders. For instance, it has been shown to inhibit the proliferation of certain cancer cells and enhance the immune response against tumors .

Recombinant Mouse Galectin-9

Recombinant Mouse Galectin-9 is produced using E. coli expression systems. The recombinant protein typically includes the amino acid sequence from Ala2 to Thr322, with a predicted molecular mass of approximately 36.4 kDa . The protein is purified to a high degree of purity (>95%) and is free from endotoxins, making it suitable for various research applications .

Applications

Recombinant Mouse Galectin-9 is widely used in research to study its biological functions and potential therapeutic applications. Some of the key applications include:

  • Immune Regulation Studies: Investigating the role of Galectin-9 in modulating immune responses, particularly in T-cell apoptosis and immune tolerance.
  • Cancer Research: Exploring the anti-tumor effects of Galectin-9 and its potential as a therapeutic agent in cancer treatment.
  • Infectious Disease Research: Studying the role of Galectin-9 in host-pathogen interactions and its potential as a therapeutic target in infectious diseases.
  • Inflammatory Disorders: Investigating the involvement of Galectin-9 in inflammatory processes and its potential as a therapeutic target in inflammatory diseases .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.